[1]CurrentPatentAssignee:NRGTHERAPEUTICS-WO2022/49376,2022,A1Locationinpatent:Page/Pagecolumn77
[2]CurrentPatentAssignee:NRGTHERAPEUTICS-WO2022/49376,2022,A1Locationinpatent:Page/Pagecolumn77
1381944-47-3
937013-96-2
1330750-48-5
1588508-95-5
1588508-93-3
124499-21-4 | tert-Butyl 2-[4-(cyanomethyl)phenoxy]acetate | AA000M1A | MFCD22375028
1245816-10-7 | 5-Methyl-1H-indazol-4-yl boronic acid | AA000MCG | MFCD10001490
1247349-99-0 | 3-Bromo-4-isobutoxyaniline | AA000MM1 | MFCD13193213
1250756-65-0 | 6-oxaspiro[2.5]octan-1-amine | AA000N0V | MFCD16744511
125256-00-0 | Fatostatin | AA000NB8 | MFCD02376000
125455-62-1 | Sodium (2R,3S,4S,5R)-2,3,4,5-tetrahydroxy-6-oxohexyl sulfate | AA000NN8 | MFCD00078771
125630-28-6 | 2-Pyrrolidinone, 1-methyl-3-(3-pyridinylcarbonyl)- | AA000NWN | MFCD00454717
1256355-55-1 | 3-(2-Methoxy-2-oxoethoxy)phenylboronic acid | AA000O1C | MFCD11973991
1256360-58-3 | 2-(Cyclopropylaminomethyl)-5-fluorophenylboronic acid, pinacol ester | AA000O5M | MFCD18087740
1256822-94-2 | 2-Bromo-6-fluoropyridin-3-ol | AA000ODA | MFCD18257625